Comments to FDA: International Scheduling Recommendations for Dronabinol and its Stereoisomers, Cannabidiol Preparations, and Pharmaceutical Preparations of Cannabis

Share page:

Comments | Mar 14, 2019

Docket Number:
FDA-2019-N-0767

CHPA has reviewed the findings of the meeting of the World Health Organization Expert Committee on Drug Dependence. CHPA agrees with the Committee's recommendations.

Related Posts

Press Releases and Statements

CHPA Welcomes Three Consumer Healthcare Industry Members

Press Releases and Statements

CHPA Statement Regarding ODSP Leadership

Press Releases and Statements

CHPA Applauds the Re-introduction of Bipartisan CBD Legislation